United Therapeutics UTHR Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from United Therapeutics’s reported figures.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is United Therapeutics's free cash flow?
- United Therapeutics (UTHR) reported free cash flow of $362.5M in Q1 2026.
- How has United Therapeutics's free cash flow changed year-over-year?
- United Therapeutics's free cash flow decreased by 6.2% year-over-year, from $386.3M to $362.5M.
- What is the long-term trend for United Therapeutics's free cash flow?
- Over 4 years (2021 to 2025), United Therapeutics's free cash flow has grown at a 21.5% compound annual growth rate (CAGR), from $477.4M to $1.04B.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.